Chunyu Xu

Jan 20, 2025 | pubs.rsc.org | Chunyu Xu |Yifan Chen |Zijin Zhao |Bowen Yang

Semi-transparent photovoltaics Semi-transparent photovoltaics (STPVs) have attracted an increasing attention thanks to their ability to seamlessly integrate power generation with light transmission. They can complement traditional opaque photovoltaics, significantly broadening their potential applications.

Nov 6, 2024 | digitalcommons.library.tmc.edu | Jiakai Hou |Shaoheng Liang |Chunyu Xu |Yanjun Wei

Genetic screens are widely exploited to develop novel therapeutic approaches for cancer treatment. With recent advances in single-cell technology, single-cell CRISPR screen (scCRISPR) platforms provide opportunities for target validation and mechanistic studies in a high-throughput manner. Here, we aim to establish scCRISPR platforms which are suitable for immune-related screens involving multiple cell types.

Apr 2, 2024 | mdpi.com | Xiao Yu Guo |Yilin Wang |Chunyu Xu |Zibo Wei

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Feb 13, 2024 | mdpi.com | Xiao Yu Guo |Yilin Wang |Chunyu Xu |Zibo Wei

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Nov 2, 2023 | biorxiv.org | Ritu Bohat |Xiaofang Liang |Yanping Chen |Chunyu Xu

AbstractSle1 and Faslpr are two lupus susceptibility loci that lead to manifestations of systemic lupus erythematosus. To evaluate dosage effects of FASlpr in determining cellular and serological phenotypes associated with lupus, we developed a new C57BL/6 (B6) congenic lupus strain, B6.Sle1/Sle1.Faslpr/+ (sle1homo.lprhet) and compared it with B6.Faslpr/lpr (lprhomo), B6.Sle1/Sle1 (sle1homo), and B6.Sle1/Sle1.Faslpr/lpr (sle1homo.lprhomo) strains.